HDAX P-IN./ DE0008469016
HDAX2024-04-23 5:50:00 PM | Chg. +136.79 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
9,675.44XXP | +1.43% | 9,563.10 | 9,678.89 | 9,563.10 | 9,538.65 |
GlobeNewswire
2016-12-13
MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire
2016-12-06
MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire
2016-12-06
MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire
2016-11-29
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-28
MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire
2016-11-25
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-22
Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....
GlobeNewswire
2016-11-21
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-21
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
2016-11-21
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
2016-11-17
MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire
2016-11-17
MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...
GlobeNewswire
2016-11-15
MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...
GlobeNewswire
2016-11-08
Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations
GlobeNewswire
2016-11-03
MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) ...
GlobeNewswire
2016-11-02
MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatol...
GlobeNewswire
2016-10-20
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody
GlobeNewswire
2016-10-17
MorphoSys Presents Updated Clinical Results for MOR202 at Medical Conference